Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 5-hydroxytryptamine receptor 6 (5-HT6 receptor, gene symbol HTR6) is a member of the G protein-coupled receptor (GPCR) family that binds serotonin (5-hydroxytryptamine, 5-HT), an important neurotransmitter in the central nervous system. It is primarily expressed in the brain and plays key roles in modulating neurotransmission and neuronal signaling. Upon binding serotonin or other agonists, it activates Gs proteins which stimulate adenylate cyclase activity, leading to increased intracellular cAMP levels. This signaling cascade influences various downstream effectors involved in neuronal activity. It has been investigated extensively as a drug target for several neuropsychiatric conditions.
Coupled via Gs protein → stimulates adenylate cyclase → ↑cAMP
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5-hydroxytryptamine receptor 6 (None).